Molekulinės onkologijos laboratorija

Svarbiausios 5-ių metų publikacijos žurnaluose, įrašytuose į mokslinės informacijos instituto (Web of Science Clarivate Analytics) sąrašą:

2018

  1. Stakišaitis D, Juknevičienė M, Ulys A, Žaliūnienė D, Stanislovaitienė D, Šepetienė R, Slavinska A, Sužiedėlis K, Lesauskaitė V. ABO blood group polymorphism has an impact on prostate, kidney and bladder cancer in association with longevity. Oncology letters. 2018; 16(1): 1321-1331. DOI:10.3892/ol.2018.8749 (IF=1,664)
  2. Stakišaitis D, Zamarytė-Sakavičienė K, Lesauskaitė V, Jankūnas RJ. Off-label use of antipsychotic agents in dementia: evidence for the revision of the reimbursement policy. Ther Innov Regul Sci. 2018; 2168479018795857: 1-5. doi: 10.1177/2168479018795857 (IF=0,882)
  3. Stanevičiūtė J, Juknevičienė M, Palubinskienė J, Balnytė I, Valančiūtė A, Vosyliūtė R, Sužiedėlis K, Lesauskaitė V, Stakišaitis D. Sodium Dichloroacetate Pharmacological Effect as Related to Na–K–2Cl Cotransporter Inhibition in Rats. Dose-Response: An International Journal. 2018; Volume: 16 issue: 4: 1-11. https://doi.org/10.1177/1559325818811522. (IF=2,435)
  4. Strainiene E, Binkis M, Urnikyte S, Stankevicius V, Sasnauskiene A, Kundrotas G, Kazlauskas A, Suziedelis K. Microenvironment dependent gene expression signatures in reprogrammed human colon normal and cancer cell lines. BMC Cancer. 2018 Feb 27;18(1):222. doi: 10.1186/s12885-018-4145-8. (IF=3,288)
  5. Skeberdytė A, Sarapinienė I, Aleksander-Krasko J, Stankevičius V, Sužiedėlis K, Jarmalaitė S. Dichloroacetate and salinomycin exert a synergistic cytotoxic effect in colorectal cancer cell lines. Scientific Reports. 2018; 8(17744):1-13. DOI:10.1038/s41598-018-35815-4. (IF=4,122)
  6. Šlekienė L, Stakišaitis D, Balnytė I, Valančiūtė A. Sodium valproate inhibits small cell lung cancer tumor growth on the chicken embryo chorioallantoic membrane and reduces the p53 and EZH2 expression. Dose-Response. 2018; 16(2):1559325818772486. (IF=2,435)

2017

  1. Baltruskeviciene E, Kazbariene B, Aleknavicius E, Krikstaponiene A, Venceviciene L, Suziedelis K, Stratilatovas E, Didziapetriene J. Changes of reduced glutathione and glutathione S-transferase levels in colorectal cancer patients undergoing treatment. Tumori. 2017:0. (IF=1,233)
  2. Baltruskeviciene E, Schveigert D, Stankevicius V, Mickys U, Zvirblis T, Bublevic J, Suziedelis K, Aleknavicius E. Down-regulation of miRNA-148a and miRNA-625-3p in colorectal cancer is associated with tumor budding. BMC Cancer. 2017; 17(1):607. (IF=3,288)
  3. Cicenas J, Tamosaitis L, KvederaviciuteK, Tarvydas R, Staniute G, Kalyan K, Meskinyte-Kausiliene E, Stankevicius V, Valius M. KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma. Medical Oncology. 2017; 34(2):26. (IF=2,634)
  4. Stankevicius V, Kunigenas L, Stankunas E, Kuodyte K, Strainiene E, Cicenas J, Samalavicius NE, Suziedelis K. The expression of cancer stem cell markers in human colorectal carcinoma cells in a microenvironment dependent manner. Biochem Biophys Res Commun. 2017; 484(4):726–33. (IF=2,466)
  5. Stankevicius V, Kuodyte K, Schveigert D, Bulotiene D, Paulauskas T, Daniunaite K, Suziedelis K. Gene and miRNA expression profiles of mouse Lewis lung carcinoma LLC1 cells following single or fractionated dose irradiation. Oncology Letters. 2017; 13(6):4190–200. (IF=1,390)
  6. Stankevicius V, Vasauskas G, Rynkeviciene R, Venius J, Pasukoniene V, Aleknavicius E, Suziedelis K. Microenvironment and Dose-Delivery-Dependent Response after Exposure to Ionizing Radiation in Human Colorectal Cancer Cell Lines. Radiat Res. 2017; 188(3):291–302. (IF=2,539)

2016

  1. Schveigert D, Krasauskas A, Didžiapetrienė J, Kalibatienė D, Cicėnas S. Smoking, hormonal factors and molecular markers in female lung cancer. Neoplasma. 2016; 63(4):504–9. (IF=1,961)
  2. Stankevicius V, Vasauskas G, Bulotiene D, Butkyte S, Jarmalaite S, Rotomskis R, Suziedelis K. Gene and miRNA expression signature of Lewis lung carcinoma LLC1 cells in extracellular matrix enriched microenvironment. BMC Cancer. 2016; 16:789. DOI 10.1186/s12885-016-2825-9. (IF=3,265)
  3. Stankevicius V, Vasauskas G, Noreikiene R, Kuodyte K, Valius M, Suziedelis K. Extracellular Matrix-dependent Pathways in Colorectal Cancer Cell Lines Reveal Potential Targets for Anticancer Therapies. Anticancer Res. 2016; 36(9):4559–67. (IF=1,826)

2015

  1. Janulionis E, Valuckas KP, Liukpetryte S, Samerdokiene V, Atkocius V. Californium versus cobalt brachytherapy combined with external-beam radiotherapy for IIB stage cervical cancer: long-term experience of a single institute. J Contemp Brachytherapy 2015; 7(5): 346–51. (IF=1,284)
  2. Liubavičiūtė A, Krasko JE, Mlynska A, Lagzdina J, Sužiedėlis K, Pašukonienė V. Evaluation of low-dose proton beam radiation efficiency in MIA PaCa-2 pancreatic cancer cell line vitality and H2AX formation. Medicina-Lithuania. 2015; 51(5):302–6; (IF=0,494)
  3. Samerdokiene V, Valuckas KP, Janulionis E, Atkocius V, Rivard MJ. Second primary malignancies after radiotherapy including HDR 252Cf brachytherapy for cervical cancer. Brachytherapy. 2015; 14(6): 898–904. (IF=2,758)
  4. Samerdokiene V, Mastauskas A, Atkocius V. Assessment of annual average effective dose status in the cohort of medical staff in lithuania during 1991-2013. Radiat Prot Dosimetry. 2015; 167(4):671–7. (IF=0,913)

2014

  1. Schveigert D, Cicenas S, Bublevic J, Askinis R, Sapoka V, Didziapetriene J. The role of genetic and other biomarkers in NSCLC prognosis. Centr Eur J Med. 2014; 9(3):382–90. (IF=0,209).

2013

  1. Krasko JA, Maksimova I, Rudgalvytė M, Pašukonienė V. Radiation induced multidrug resistance in breast cancer – laboratory model. Proceedings of the 11th International Conference „Medical Physics in the Baltic States“. Kaunas, Lietuva. Technologija. 2013; 11:8–11.
  2. Lagzdina E, Gaspariūnas M, Plukienė R, Plukis A, Pašukonienė V, Sužiedėlis K, Kovalevskij V. The application of 1.6 MeV proton microbeam to investigate radiation-induced bystander effect in MIA PaCa-2 pancreatic cancer cell line. Proceedings of the 11th International Conference „Medical Physics in the Baltic States“. Kaunas, Lietuva. Technologija. 2013; 67–70.
  3. Povilonis J, Seputiene V, Krasauskas R, Juskaite R, Miskinyte M, Suziedelis K, Suziedeliene E. Spread of carbapenem-resistant Acinetobacter baumannii carrying a plasmid with two genes encoding OXA-72 carbapenemase in Lithuanian hospitals. J Antimicrob Chemother. 2013; 68(5):1000–6. (IF=5,338)
  4. Samerdokienė V, Atkocius V, Ofomala R. Radiation exposure received by the medical radiation workers in Lithuania at Institute of Oncology, Vilnius University, 2004-2011. Radiat Prot Dosimetry. 2013; 157(1):152–7. (IF=0,861)
  5. Schveigert D, Cicenas S, Bruzas S, Samalavicius NE, Gudleviciene Z, Didziapetriene J. The value of MMP-9 for breast and non-small cell lung cancer patients‘ survival. Adv Med Sci. 2013; 58(1):73–82. (IF=0,964)
  6. Schveigert D, Valuckas KP, Kovalcis V, Ulys A, Chvatovic G, Didziapetriene J. Significance of MMP-9 expression and MMP-9 polymorphism in prostate cancer. Tumori. 2013; 99(4):523–9. (IF=1,09)

 



Atnaujinta 2019-03-25 12:35